Contact
Please use this form to send email to PR contact of this press release:
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
TO:
Please use this form to send email to PR contact of this press release:
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
TO: